“…Additionally, various case reports have been published reporting ischemic events, including infarction [17,18]. Adrenergic receptors expressed on the surface of platelets increase platelet activation [20], and in a study conducted by Hallbäck et al [34], results showed that SNRIs, such as venlafaxine, increased adhesion by possibly acting on these receptors, perhaps providing an explanation for the alterations in platelet morphology as observed in this study.…”